Prostatic atrophy antiphlogistic injection liquid

Abstract

The present invention discloses a Qianliexian Weisuokangyan injection for effectively curing hyperplasia of prostate and prostatic hypertrophy with chronic prostatitis. It is made up by mixing 25% (g.wt / 100ml) sorbitol injection 4 ml, 10% vitamin C injection 2 ml, 1% L-ofloxacin injection 2 ml and 2% lidocaine injection 2 ml.

Description

technical field [0001] The invention relates to an injection medicine, in particular to a prostate atrophy anti-inflammatory injection for treating benign prostatic hyperplasia and hypertrophy with chronic prostatitis. Background technique [0002] Prostate diseases, such as benign prostatic hyperplasia and hypertrophy with prostatitis, are unique to men, and their incidence increases with age. According to statistics, about half of men over the age of 40 suffer from benign prostatic hyperplasia, and the incidence rate over the age of 80 can reach more than 90%. Life brings troubles, and severe urinary retention leads to renal function damage. Drug treatment of benign prostatic hyperplasia, currently mostly adopts oral administration method, the active ingredient reaching the affected area is less, the course of treatment is long, the effect is slow, and the condition often rebounds after stopping the drug, and the effect is not ideal. Contents of the invention [0003] ...

AI Technical Summary

Problems solved by technology

Drug treatment of benign prostatic hyperplasia, currently mostly adopts oral administration method, less active ingredients reach the affected area, long course of treatment, slow effect, and often rebound after drug withdrawal, the effect is not ideal